Graft survival prolongation with porphyrins

Details Graft survival prolongation with porphyrins Graft survival prolongation with porphyrins

1998-03-20

2000-05-09

Cook, Rebecca

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

514885, A61K 5504

Patent

active

060604670

ABSTRACT:
Metalloporphyrins are administered in conjunction with transplantation to enhance the survival of the organ.

REFERENCES:
patent: 4829984 (1989-05-01), Gordon
patent: 5563132 (1996-10-01), Bodaness
Abraham et al., Int. J. Biochem., 20(6):543-558 (1988).
Vulapalli and Maines, Biochimica et Biophysica Acta, 1217:273-280 (1994).
Neil et al., Journal of Ocular Pharmacology and Therapeutics 11(3):455-468 (1995).
Haga et al., Biochimica et Biophysica Acta 1316:29-34 (1996).
Willis et al., Nature Medicine 2(1):87-90 (1996).
Agarwal et al., Transplantation 61:93-98 (1996).
Maines, Biochimica et Biophysica Acta 673:339-350 (1981).
Drummond and Kappas, Proc. Natl. Acad. Sci. USA 78(10):6466-6470 (1981).
Tenhunen et al., The Journal of Biological Chemistry 244(23):6388-6394 (1969).
Sinal et al., Canadian Journal of Physiology and Pharmacology 73:146-152 (1995).
Martasek et al., Biochemical and Biophysical Research Communications 157(2):480-487 (1988).

Affiliated with

Also associated with

Rating

Graft survival prolongation with porphyrins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Graft survival prolongation with porphyrins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Graft survival prolongation with porphyrins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1065266